
Title:
Amoxicillin
Text:
Beta-lactam antibiotic


.mw-parser-output .hatnote{font-style:italic}.mw-parser-output div.hatnote{padding-left:1.6em;margin-bottom:0.5em}.mw-parser-output .hatnote i{font-style:normal}.mw-parser-output .hatnote+link+.hatnote{margin-top:-0.5em}Not to be confused with Ampicillin.
.mw-parser-output .infobox-subbox{padding:0;border:none;margin:-3px;width:auto;min-width:100%;font-size:100%;clear:none;float:none;background-color:transparent}.mw-parser-output .infobox-3cols-child{margin:auto}.mw-parser-output .infobox .navbar{font-size:100%}body.skin-minerva .mw-parser-output .infobox-header,body.skin-minerva .mw-parser-output .infobox-subheader,body.skin-minerva .mw-parser-output .infobox-above,body.skin-minerva .mw-parser-output .infobox-title,body.skin-minerva .mw-parser-output .infobox-image,body.skin-minerva .mw-parser-output .infobox-full-data,body.skin-minerva .mw-parser-output .infobox-below{text-align:center}AmoxicillinClinical dataPronunciation/əˌmɒksɪˈsɪlɪn/ Trade namesHundreds of names[1]Other namesAmoxycillin, amox, amoxycillin (AAN AU)AHFS/Drugs.comMonographMedlinePlusa685001License data
US DailyMed: Amoxicillin
Pregnancycategory
AU: A

Routes ofadministrationBy mouth, intravenousDrug classβ-lactam antibioticATC codeJ01CA04 (WHO) QG51AA03 (WHO)Legal statusLegal status
AU: S4 (Prescription only) 
UK: POM (Prescription only) 
US: ℞-only 
In general: ℞ (Prescription only)
Pharmacokinetic dataBioavailability95% by mouthMetabolismless than 30% biotransformed in liverElimination half-life61.3 minutesExcretionKidneysIdentifiers
IUPAC name
(2S,5R,6R)-6-{[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
CAS Number26787-78-0 YPubChem CID33613DrugBankDB01060 YChemSpider31006 YUNII9EM05410Q9KEGGD07452 YChEBICHEBI:2676 YChEMBLChEMBL1082 YCompTox Dashboard (EPA)DTXSID3037044 ECHA InfoCard100.043.625 Chemical and physical dataFormulaC16H19N3O5SMolar mass365.40 g·mol−13D model (JSmol)Interactive imageDensity1.6±0.1 [2] g/cm3
SMILES
O=C(O)[C@@H]2N3C(=O)[C@@H](NC(=O)[C@@H](c1ccc(O)cc1)N)[C@H]3SC2(C)C

InChI
InChI=1S/C16H19N3O5S/c1-16(2)11(15(23)24)19-13(22)10(14(19)25-16)18-12(21)9(17)7-3-5-8(20)6-4-7/h3-6,9-11,14,20H,17H2,1-2H3,(H,18,21)(H,23,24)/t9-,10-,11+,14-/m1/s1 YKey:LSQZJLSUYDQPKJ-NJBDSQKTSA-N Y
.mw-parser-output .nobold{font-weight:normal}  (verify)
Amoxicillin is an antibiotic used to treat a number of bacterial infections.[3] These include middle ear infection, strep throat, pneumonia, skin infections, and urinary tract infections among others.[3] It is taken by mouth, or less commonly by injection.[3][4]
Common adverse effects include nausea and rash.[3] It may also increase the risk of yeast infections and, when used in combination with clavulanic acid, diarrhea.[5] It should not be used in those who are allergic to penicillin.[3] While usable in those with kidney problems, the dose may need to be decreased.[3] Its use in pregnancy and breastfeeding does not appear to be harmful.[3] Amoxicillin is in the beta-lactam family of antibiotics.[3]
Amoxicillin was discovered in 1958 and came into medical use in 1972.[6][7] It is on the World Health Organization's List of Essential Medicines.[8] It is one of the most commonly prescribed antibiotics in children.[9] Amoxicillin is available as a generic medication.[3]  In 2019, it was the 23rd most commonly prescribed medication in the United States, with more than 25 million prescriptions.[10][11]

Contents

1 Medical uses

1.1 Acute otitis media
1.2 Respiratory infections
1.3 H. pylori
1.4 Lyme borreliosis
1.5 Skin infections
1.6 Infections in infants in resource-limited settings
1.7 Prevention of bacterial endocarditis
1.8 Combination treatment
1.9 Spectrum of activity


2 Adverse effects

2.1 Nonallergic rash


3 Interactions
4 Pharmacology
5 History
6 Society and culture

6.1 Cost
6.2 Modes of delivery
6.3 Names


7 Other animals
8 References
9 Further reading
10 External links



Medical uses[edit]
  Amoxicillin BP
Amoxicillin is used in the treatment of a number of infections, including acute otitis media, streptococcal pharyngitis, pneumonia, skin infections, urinary tract infections, Salmonella infections, Lyme disease, and chlamydia infections.[3][12]

Acute otitis media[edit]
Children with acute otitis media who are younger than 6 months of age are generally treated with amoxicillin or other antibiotics. Although most children with acute otitis media who are older than two years old do not benefit from treatment with amoxicillin or other antibiotics, such treatment may be helpful in children younger than two years old with acute otitis media that is bilateral or accompanied by ear drainage.[13] In the past, amoxicillin was dosed three times daily when used to treat acute otitis media, which resulted in missed doses in routine ambulatory practice. There is now evidence that two times daily dosing or once daily dosing has similar effectiveness.[14]

Respiratory infections[edit]
Amoxicillin and amoxicillin-clavulanate have been recommended by guidelines as the drug of choice for bacterial sinusitis and other respiratory infections.[12] Most sinusitis infections are caused by viruses, for which amoxicillin and amoxicillin-clavulanate are ineffective,[15] and the small benefit gained by amoxicillin may be overridden by the adverse effects.[16] 
Amoxicillin is recommended as the preferred first-line treatment for community-acquired pneumonia in adults by the National Institute for Health and Care Excellence, either alone (mild to moderate severity disease) or in combination with a macrolide.[17] The World Health Organization (WHO) recommends amoxicillin as first-line treatment for pneumonia that is not "severe".[18] Amoxicillin is used in post-exposure inhalation of anthrax to prevent disease progression and for prophylaxis.[12]

H. pylori[edit]
It is effective as one part of a multi-drug regimen for treatment of stomach infections of Helicobacter pylori. It is typically combined with a proton-pump inhibitor (such as omeprazole) and a macrolide antibiotic (such as clarithromycin); other drug combinations are also effective.[19]

Lyme borreliosis[edit]
Amoxicillin is effective for treatment of early cutaneous Lyme borreliosis; the effectiveness and safety of oral amoxicillin is neither better nor worse than common alternatively-used antibiotics.[20]

Skin infections[edit]
Amoxicillin is occasionally used for the treatment of skin infections,[12] such as acne vulgaris.[21] It is often an effective treatment for cases of acne vulgaris that have responded poorly to other antibiotics, such as doxycycline and minocycline.[22]

Infections in infants in resource-limited settings[edit]
Amoxicillin is recommended by the World Health Organization for the treatment of infants with signs and symptoms of pneumonia in resource-limited situations when the parents are unable or unwilling to accept hospitalization of the child. Amoxicillin in combination with gentamicin is recommended for the treatment of infants with signs of other severe infections when hospitalization is not an option.[23]

Prevention of bacterial endocarditis[edit]
It is also used to prevent bacterial endocarditis and as a pain-reliever in high-risk people having dental work done, to prevent Streptococcus pneumoniae and other encapsulated bacterial infections in those without spleens, such as people with sickle-cell disease, and for both the prevention and the treatment of anthrax.[3] The United Kingdom recommends against its use for infectious endocarditis prophylaxis.[24] These recommendations do not appear to have changed the rates of infection for infectious endocarditis.[25]

Combination treatment[edit]
Amoxicillin is susceptible to degradation by β-lactamase-producing bacteria, which are resistant to most β-lactam antibiotics, such as penicillin. For this reason, it may be combined with clavulanic acid, a β-lactamase inhibitor. This drug combination is commonly called co-amoxiclav.[26]

Spectrum of activity[edit]
It is a moderate-spectrum, bacteriolytic, β-lactam antibiotic in the aminopenicillin family used to treat susceptible Gram-positive and Gram-negative bacteria. It is usually the drug of choice within the class because it is better-absorbed, following oral administration, than other β-lactam antibiotics. 
In general, Streptococcus, Bacillus subtilis, Enterococcus, Haemophilus, Helicobacter, and Moraxella are susceptible to amoxicillin, whereas Citrobacter, Klebsiella and Pseudomonas aeruginosa are resistant to it.[27] Some E. coli and most clinical strains of Staphylococcus aureus have developed resistance to amoxicillin to varying degrees.

Adverse effects[edit]
Adverse effects are similar to those for other β-lactam antibiotics, including nausea, vomiting, rashes, and antibiotic-associated colitis. Loose bowel movements (diarrhea) may also occur. Rarer adverse effects include mental changes, lightheadedness, insomnia, confusion, anxiety, sensitivity to lights and sounds, and unclear thinking. Immediate medical care is required upon the first signs of these adverse effects.[citation needed]
The onset of an allergic reaction to amoxicillin can be very sudden and intense; emergency medical attention must be sought as quickly as possible. The initial phase of such a reaction often starts with a change in mental state, skin rash with intense itching (often beginning in fingertips and around groin area and rapidly spreading), and sensations of fever, nausea, and vomiting. Any other symptoms that seem even remotely suspicious must be taken very seriously.  However, more mild allergy symptoms, such as a rash, can occur at any time during treatment, even up to a week after treatment has ceased.  For some people allergic to amoxicillin, the adverse effects can be fatal due to anaphylaxis.
Use of the amoxicillin/clavulanic acid combination for more than one week has caused a drug-induced immunoallergic-type hepatitis in some patients. Young children having ingested acute overdoses of amoxicillin manifested lethargy, vomiting, and renal dysfunction.[28][29]
There is poor reporting of adverse effects of amoxicillin from clinical trials. For this reason, the severity and frequency of adverse effects from amoxicillin is probably higher than reported from clinical trials.[30]

Nonallergic rash[edit]
Between 3 and 10% of children taking amoxicillin (or ampicillin) show a late-developing (>72 hours after beginning medication and having never taken penicillin-like medication previously) rash, which is sometimes referred to as the "amoxicillin rash". The rash can also occur in adults and may rarely be a component of the DRESS syndrome.
The rash is described as maculopapular or morbilliform (measles-like; therefore, in medical literature, it is called "amoxicillin-induced morbilliform rash".[31]). It starts on the trunk and can spread from there. This rash is unlikely to be a true allergic reaction and is not a contraindication for future amoxicillin usage, nor should the current regimen necessarily be stopped. However, this common amoxicillin rash and a dangerous allergic reaction cannot easily be distinguished by inexperienced persons, so a healthcare professional is often required to distinguish between the two.[32][33]
A nonallergic amoxicillin rash may also be an indicator of infectious mononucleosis. Some studies indicate about 80-90% of patients with acute Epstein Barr virus infection treated with amoxicillin or ampicillin develop such a rash.[34]


		
			
			
Nonallergic amoxicillin rash eight days after first dose: This photo was taken 24 hours after the rash began.

			
		
		
			
			
Eight hours after the first photo, individual spots have grown and begun to merge.

			
		
		
			
			
At 23 hours after the first photo, the color appears to be fading, and much of rash has spread to confluence.

			
		

Interactions[edit]
Amoxicillin may interact with these drugs:

Anticoagulants (dabigatran, warfarin).[35][12]
Cancer treatment (methotrexate).
Uricosuric drugs.
Typhoid vaccine[36]
Probenecid reduces renal excretion and increases the blood levels of amoxicillin.
Oral contraceptives may become less effective.
Allopurinol (gout treatment).


Pharmacology[edit]
Amoxicillin (α-amino-p-hydroxybenzyl penicillin) is a semisynthetic derivative of penicillin with a structure similar to ampicillin but with better absorption when taken by mouth, thus yielding higher concentrations in blood and in urine.[37]  Amoxicillin diffuses easily into tissues and body fluids. It will cross the placenta and is excreted into breastmilk in small quantities. It is metabolized by the liver and excreted into the urine. It has an onset of 30 minutes and a half-life of 3.7 hours in newborns and 1.4 hours in adults.[12]
Amoxicillin attaches to the cell wall of susceptible bacteria and results in their death. It also is a bactericidal compound. It is effective against streptococci, pneumococci, enterococci, Haemophilus influenzae, Escherichia coli, Proteus mirabilis, Neisseria meningitidis, Neisseria gonorrhoeae, Shigella, Chlamydia trachomatis, Salmonella, Borrelia burgdorferi, and Helicobacter pylori.[12] As a derivative of ampicillin, amoxicillin is a member of the penicillin family and, like penicillins, is a β-lactam antibiotic.[38] It inhibits cross-linkage between the linear peptidoglycan polymer chains that make up a major component of the bacterial cell wall. 
It has two ionizable groups in the physiological range (the amino group in alpha-position to the amide carbonyl group and the carboxyl group).[39]

History[edit]
See also: Timeline of antibiotics
Amoxicillin was one of several semisynthetic derivatives of 6-aminopenicillanic acid (6-APA) developed by the Beecham Group in the 1960s.[40][41] It became available in 1972 and was the second aminopenicillin to reach the market (after ampicillin in 1961).[42][43][44] Co-amoxiclav became available in 1981.[43]

Society and culture[edit]
Cost[edit]
Amoxicillin is relatively inexpensive.[45]

Modes of delivery[edit]
Pharmaceutical manufacturers make amoxicillin in trihydrate form, for oral use available as capsules, regular, chewable and dispersible tablets, syrup and pediatric suspension for oral use, and as the sodium salt for intravenous administration.  Amoxicillin is most commonly taken orally. The liquid forms are helpful where the patient might find it difficult to take tablets or capsules.
An extended-release is available.[46] The intravenous form of amoxicillin is not sold in the United States.[47] When an intravenous aminopenicillin is required in the United States, ampicillin is typically used. When there is an adequate response to ampicillin, the course of antibiotic therapy may often be completed with oral amoxicillin.[48]
Research with mice indicated successful delivery using intraperitoneally injected amoxicillin-bearing microparticles.[49]

Names[edit]
"Amoxicillin" is the International Nonproprietary Name (INN), British Approved Name (BAN), and United States Adopted Name (USAN), while "amoxycillin" is the Australian Approved Name (AAN).
Amoxicillin is one of the semisynthetic penicillins discovered by Beecham scientists. The patent for amoxicillin has expired, thus amoxicillin and co-amoxiclav preparations are marketed under various trade names across the world.[1]

Other animals[edit]
Amoxicillin is also sometimes used as an antibiotic for animals.  The use of amoxicillin for animals intended for human consumption (chickens, cattle, and swine for example) has been approved.[50]

References[edit]
.mw-parser-output .reflist{font-size:90%;margin-bottom:0.5em;list-style-type:decimal}.mw-parser-output .reflist .references{font-size:100%;margin-bottom:0;list-style-type:inherit}.mw-parser-output .reflist-columns-2{column-width:30em}.mw-parser-output .reflist-columns-3{column-width:25em}.mw-parser-output .reflist-columns{margin-top:0.3em}.mw-parser-output .reflist-columns ol{margin-top:0}.mw-parser-output .reflist-columns li{page-break-inside:avoid;break-inside:avoid-column}.mw-parser-output .reflist-upper-alpha{list-style-type:upper-alpha}.mw-parser-output .reflist-upper-roman{list-style-type:upper-roman}.mw-parser-output .reflist-lower-alpha{list-style-type:lower-alpha}.mw-parser-output .reflist-lower-greek{list-style-type:lower-greek}.mw-parser-output .reflist-lower-roman{list-style-type:lower-roman}

^ Jump up to: a b .mw-parser-output cite.citation{font-style:inherit;word-wrap:break-word}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .citation:target{background-color:rgba(0,127,255,0.133)}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .cs1-ws-icon a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg")right 0.1em center/12px no-repeat}.mw-parser-output .cs1-code{color:inherit;background:inherit;border:none;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;color:#d33}.mw-parser-output .cs1-visible-error{color:#d33}.mw-parser-output .cs1-maint{display:none;color:#3a3;margin-left:0.3em}.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}"International brand names for amoxicillin". www.drugs.com. Drugs.com. Archived from the original on 29 May 2016. Retrieved 15 November 2016.

^ "Amoxicillin". www.chemsrc.com.

^ Jump up to: a b c d e f g h i j k "Amoxicillin". The American Society of Health-System Pharmacists. Archived from the original on 5 September 2015. Retrieved 1 August 2015.

^ "Amoxicillin Sodium for Injection". EMC. 10 February 2016. Archived from the original on 27 October 2016. Retrieved 26 October 2016.

^ Gillies M, Ranakusuma A, Hoffmann T, Thorning S, McGuire T, Glasziou P, Del Mar C (January 2015). "Common harms from amoxicillin: a systematic review and meta-analysis of randomized placebo-controlled trials for any indication". CMAJ. 187 (1): E21–E31. doi:10.1503/cmaj.140848. PMC 4284189. PMID 25404399.

^ Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 490. ISBN 978-3-527-60749-5. Archived from the original on 8 September 2017.

^ Roy J (2012). An introduction to pharmaceutical sciences production, chemistry, techniques and technology. Cambridge: Woodhead Pub. p. 239. ISBN 978-1-908818-04-1. Archived from the original on 8 September 2017.

^ World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.

^ Kelly D (2008). Diseases of the liver and biliary system in children (3 ed.). Chichester, UK: Wiley-Blackwell. p. 217. ISBN 978-1-4443-0054-3. Archived from the original on 8 September 2017.

^ "The Top 300 of 2019". ClinCalc. Retrieved 16 October 2021.

^ "Amoxicillin Drug Usage Statistics". ClinCalc. Retrieved 16 October 2021.

^ Jump up to: a b c d e f g "Amoxicillin" (PDF). Davis. 2017. Archived (PDF) from the original on 8 September 2017. Retrieved 22 March 2017.

^ Venekamp RP, Sanders SL, Glasziou PP, Del Mar CB, Rovers MM (June 2015). "Antibiotics for acute otitis media in children". The Cochrane Database of Systematic Reviews (6): CD000219. doi:10.1002/14651858.CD000219.pub4. PMC 7043305. PMID 26099233.

^ Thanaviratananich S, Laopaiboon M, Vatanasapt P (December 2013). "Once or twice daily versus three times daily amoxicillin with or without clavulanate for the treatment of acute otitis media". The Cochrane Database of Systematic Reviews (12): CD004975. doi:10.1002/14651858.CD004975.pub3. PMID 24338106.

^ American Academy of Allergy, Asthma, and Immunology. "Five Things Physicians and Patients Should Question" (PDF). Choosing Wisely: An Initiative of the ABIM Foundation. American Academy of Allergy, Asthma, and Immunology. Archived (PDF) from the original on 3 November 2012. Retrieved 14 August 2012.{{cite journal}}:  CS1 maint: uses authors parameter (link)

^ Ahovuo-Saloranta A, Rautakorpi UM, Borisenko OV, Liira H, Williams JW, Mäkelä M (February 2014).  Ahovuo-Saloranta A (ed.). "Antibiotics for acute maxillary sinusitis in adults". The Cochrane Database of Systematic Reviews (2): CD000243. doi:10.1002/14651858.CD000243.pub3. PMID 24515610.  (Retracted, see doi:10.1002/14651858.cd000243.pub4. If this is an intentional citation to a retracted paper, please replace {{Retracted}} with {{Retracted|intentional=yes}}.)

^ Pneumonia - National Library of Medicine - PubMed Health. National Institute for Health and Care Excellence: Clinical Guidelines. National Institute for Health and Care Excellence (UK). 2014. Archived from the original on 8 September 2017.

^ Revised WHO Classification and Treatment of Pneumonia in Children at Health Facilities - NCBI Bookshelf. WHO Guidelines Approved by the Guidelines Review Committee. World Health Organization. 2014. ISBN 978-92-4-150781-3. Archived from the original on 8 September 2017.

^ Chey WD, Leontiadis GI, Howden CW, Moss SF (February 2017). "ACG Clinical Guideline: Treatment of Helicobacter pylori Infection". The American Journal of Gastroenterology. 112 (2): 212–239. doi:10.1038/ajg.2016.563. PMID 28071659. S2CID 9390953.

^ Torbahn G, Hofmann H, Rücker G, Bischoff K, Freitag MH, Dersch R,  et al. (November 2018). "Efficacy and Safety of Antibiotic Therapy in Early Cutaneous Lyme Borreliosis: A Network Meta-analysis". JAMA Dermatology. 154 (11): 1292–1303. doi:10.1001/jamadermatol.2018.3186. PMC 6248135. PMID 30285069.

^ "Adolescent Acne: Management". Archived from the original on 22 December 2010.

^ "Amoxicillin and Acne Vulgaris". scienceofacne.com. 5 September 2012. Archived from the original on 21 July 2012. Retrieved 17 August 2012.

^ Guideline: Managing Possible Serious Bacterial Infection in Young Infants When Referral Is Not Feasible - NCBI Bookshelf. WHO Guidelines Approved by the Guidelines Review Committee. World Health Organization. 2015. ISBN 978-92-4-150926-8. Archived from the original on 8 September 2017.

^ "CG64 Prophylaxis against infective endocarditis: Full guidance" (PDF). NICE. Archived from the original (PDF) on 12 November 2011. Retrieved 8 June 2011.

^ Thornhill MH, Dayer MJ, Forde JM, Corey GR, Chu VH, Couper DJ, Lockhart PB (May 2011). "Impact of the NICE guideline recommending cessation of antibiotic prophylaxis for prevention of infective endocarditis: before and after study". BMJ. 342: d2392. doi:10.1136/bmj.d2392. PMC 3086390. PMID 21540258.

^ "Amoxicillin Susceptibility and Resistance Data" (PDF). Archived from the original (PDF) on 13 July 2019. Retrieved 20 July 2013.

^ "Amoxicillin spectrum of bacterial susceptibility and Resistance" (PDF). Archived from the original (PDF) on 22 December 2018. Retrieved 8 April 2012.

^ Cundiff J, Joe S (January 2007). "Amoxicillin-clavulanic acid-induced hepatitis". American Journal of Otolaryngology. 28 (1): 28–30. doi:10.1016/j.amjoto.2006.06.007. PMID 17162128.

^ Baselt R (2008). Disposition of Toxic Drugs and Chemicals in Man (8th ed.). Foster City, CA: Biomedical Publications. pp. 81–83.

^ Gillies M, Ranakusuma A, Hoffmann T, Thorning S, McGuire T, Glasziou P, Del Mar C (January 2015). "Common harms from amoxicillin: a systematic review and meta-analysis of randomized placebo-controlled trials for any indication". CMAJ. 187 (1): E21–E31. doi:10.1503/cmaj.140848. PMC 4284189. PMID 25404399.

^ Barbaud AM, Béné MC, Schmutz JL, Ehlinger A, Weber M, Faure GC (April 1997). "Role of delayed cellular hypersensitivity and adhesion molecules in amoxicillin-induced morbilliform rashes". Archives of Dermatology. 133 (4): 481–6. doi:10.1001/archderm.1997.03890400081011. PMID 9126012. INIST:2654598.

^ Pichichero ME (April 2005). "A review of evidence supporting the American Academy of Pediatrics recommendation for prescribing cephalosporin antibiotics for penicillin-allergic patients". Pediatrics. 115 (4): 1048–57. doi:10.1542/peds.2004-1276. PMID 15805383. S2CID 21246804.

^ Schmitt BD (2005). Your child's health: the parents' one-stop reference guide to symptoms, emergencies, common illnesses, behavior problems, healthy development (2nd ed.). New York: Bantam Books. ISBN 978-0-553-38369-0.

^ Kagan BM (April 1977). "Ampicillin rash". The Western Journal of Medicine. 126 (4): 333–5. PMC 1237570. PMID 855325.

^ British National Formulary 57 March 2009

^ Arcangelo VP, Peterson AM, Wilbur V, Reinhold JA (17 August 2016). Pharmacotherapeutics for Advanced Practice: A Practical Approach. LWW. ISBN 978-1-496-31996-8.

^ Handsfield HH, Clark H, Wallace JF, Holmes KK, Turck M (February 1973). "Amoxicillin, a new penicillin antibiotic". Antimicrobial Agents and Chemotherapy. 3 (2): 262–5. doi:10.1128/AAC.3.2.262. PMC 444397. PMID 4208282.

^ Alcamo IE (2003). Microbes and Society: An Introduction to Microbiology. Jones & Bartlett Learning. p. 198. ISBN 978-0-7637-1430-7.

^ Sezer AD, ed. (2016). Application of Nanotechnology in Drug Delivery. INTECH. p. 423. ISBN 978-953-51-1628-8. Retrieved 24 July 2019.

^ .mw-parser-output .citation{word-wrap:break-word}.mw-parser-output .citation:target{background-color:rgba(0,127,255,0.133)}GB patent 978178, John Herbert Charles Nayler & Harry Smith, "Penicillins", published 1964-12-16,  assigned to Beecham Research Laboratories Ltd 

^ GB patent 1241844, Anthony Alfred Walter Long & John Herber Charles Nayler, "Penicillins", published 1971-08-04,  assigned to Beecham Group LTD 

^ Geddes AM, Klugman KP, Rolinson GN (December 2007). "Introduction: historical perspective and development of amoxicillin/clavulanate". International Journal of Antimicrobial Agents. 30 Suppl 2: S109-12. doi:10.1016/j.ijantimicag.2007.07.015. PMID 17900874.

^ Jump up to: a b Raviña E (2014). The Evolution of Drug Discovery. Weinheim: Wiley-VCH. p. 262. ISBN 978-3-527-32669-3.

^ Bruggink A (2001). Synthesis of β-lactam antibiotics. Springer. p. 17. ISBN 978-0-7923-7060-4.

^ Hanno PM, Guzzo TJ, Malkowicz SB, Wein AJ (2014). Penn Clinical Manual of Urology E-Book. Elsevier Health Sciences. p. 122. ISBN 978-0-323-24466-4.

^ "Drug Approval Package: Moxatag (amoxicillin extended-release) NDA #050813".

^ Marek CL, Timmons SR (2018).  Nowak A (ed.). Pediatric Dentistry: Infancy Through Adolescence. Saunders. ISBN 978-0-323-60826-8.

^ https://www.safetyandquality.gov.au/wp-content/uploads/2012/02/4.3-A-Quick-Guide-to-Switch_Southern-Health.pdf

^ Farazuddin M, Chauhan A, Khan RM, Owais M (August 2011). "Amoxicillin-bearing microparticles: potential in the treatment of Listeria monocytogenes infection in Swiss albino mice". Bioscience Reports. 31 (4): 265–72. doi:10.1042/BSR20100027. PMID 20687896.

^ Ramos F, Boison J, Friedlander LG. "Amoxicillin" (PDF). fao.org. Food and Agriculture Organization of the United Nations. Retrieved 8 November 2019.


Further reading[edit]
Neal MJ (2002). Medical Pharmacology at a Glance (4th ed.). Oxford: Blackwell Science. ISBN 978-0-632-05244-8.
British National Formulary 45, March 2003
External links[edit]
"Amoxicillin". Drug Information Portal. U.S. National Library of Medicine.
.mw-parser-output .navbox{box-sizing:border-box;border:1px solid #a2a9b1;width:100%;clear:both;font-size:88%;text-align:center;padding:1px;margin:1em auto 0}.mw-parser-output .navbox .navbox{margin-top:0}.mw-parser-output .navbox+.navbox,.mw-parser-output .navbox+.navbox-styles+.navbox{margin-top:-1px}.mw-parser-output .navbox-inner,.mw-parser-output .navbox-subgroup{width:100%}.mw-parser-output .navbox-group,.mw-parser-output .navbox-title,.mw-parser-output .navbox-abovebelow{padding:0.25em 1em;line-height:1.5em;text-align:center}.mw-parser-output .navbox-group{white-space:nowrap;text-align:right}.mw-parser-output .navbox,.mw-parser-output .navbox-subgroup{background-color:#fdfdfd}.mw-parser-output .navbox-list{line-height:1.5em;border-color:#fdfdfd}.mw-parser-output .navbox-list-with-group{text-align:left;border-left-width:2px;border-left-style:solid}.mw-parser-output tr+tr>.navbox-abovebelow,.mw-parser-output tr+tr>.navbox-group,.mw-parser-output tr+tr>.navbox-image,.mw-parser-output tr+tr>.navbox-list{border-top:2px solid #fdfdfd}.mw-parser-output .navbox-title{background-color:#ccf}.mw-parser-output .navbox-abovebelow,.mw-parser-output .navbox-group,.mw-parser-output .navbox-subgroup .navbox-title{background-color:#ddf}.mw-parser-output .navbox-subgroup .navbox-group,.mw-parser-output .navbox-subgroup .navbox-abovebelow{background-color:#e6e6ff}.mw-parser-output .navbox-even{background-color:#f7f7f7}.mw-parser-output .navbox-odd{background-color:transparent}.mw-parser-output .navbox .hlist td dl,.mw-parser-output .navbox .hlist td ol,.mw-parser-output .navbox .hlist td ul,.mw-parser-output .navbox td.hlist dl,.mw-parser-output .navbox td.hlist ol,.mw-parser-output .navbox td.hlist ul{padding:0.125em 0}.mw-parser-output .navbox .navbar{display:block;font-size:100%}.mw-parser-output .navbox-title .navbar{float:left;text-align:left;margin-right:0.5em}.mw-parser-output .navbar{display:inline;font-size:88%;font-weight:normal}.mw-parser-output .navbar-collapse{float:left;text-align:left}.mw-parser-output .navbar-boxtext{word-spacing:0}.mw-parser-output .navbar ul{display:inline-block;white-space:nowrap;line-height:inherit}.mw-parser-output .navbar-brackets::before{margin-right:-0.125em;content:"[ "}.mw-parser-output .navbar-brackets::after{margin-left:-0.125em;content:" ]"}.mw-parser-output .navbar li{word-spacing:-0.125em}.mw-parser-output .navbar a>span,.mw-parser-output .navbar a>abbr{text-decoration:inherit}.mw-parser-output .navbar-mini abbr{font-variant:small-caps;border-bottom:none;text-decoration:none;cursor:inherit}.mw-parser-output .navbar-ct-full{font-size:114%;margin:0 7em}.mw-parser-output .navbar-ct-mini{font-size:114%;margin:0 4em}vteAntibacterials active on the cell wall and envelope (J01C-J01D)Beta-lactams(inhibit synthesisof peptidoglycanlayer of bacterialcell wall by bindingto and inhibitingPBPs, a group ofD-alanyl-D-alaninetranspeptidases)Penicillins (Penams)Narrowspectrumβ-lactamase sensitive(1st generation)
Benzylpenicillin (G)#
Benzathine benzylpenicillin#
Procaine benzylpenicillin#
Phenoxymethylpenicillin (V)#
Propicillin‡
Pheneticillin‡
Azidocillin‡
Clometocillin‡
Penamecillin‡
β-lactamase resistant(2nd generation)
Cloxacillin# (Dicloxacillin
Flucloxacillin)
Oxacillin
Nafcillin
Methicillin‡
ExtendedspectrumAminopenicillins (3rd generation)
Amoxicillin#
Ampicillin# (Pivampicillin
Hetacillin‡
Bacampicillin‡
Metampicillin‡
Talampicillin‡)
Epicillin‡
Carboxypenicillins (4th generation)
Ticarcillin
Carbenicillin‡ / Carindacillin‡
Temocillin‡
Ureidopenicillins (4th generation)
Piperacillin
Azlocillin‡
Mezlocillin‡
Other
Mecillinam (Pivmecillinam)
Sulbenicillin‡
Carbapenems / Penems
Carbapenems (Ertapenem
Antipseudomonal (Doripenem
Imipenem
Meropenem)
Biapenem‡
Panipenem)
Penems (Faropenem
Ritipenem§)
CephemsCephalosporinsCephamycinsCarbacephems1st generation
Cefazolin#
Cefalexin #
Cefadroxil
Cefapirin
Cefazedone‡
Cefazaflur‡
Cefradine‡
Cefroxadine‡
Ceftezole‡
Cefaloglycin‡
Cefacetrile‡
Cefalonium‡
Cefaloridine‡
Cefalotin
Cefatrizine‡
2nd generation
Cefaclor
Cefprozil
Cefuroxime
Cefuroxime axetil
Cefamandole‡
Cefonicid‡
Ceforanide‡
Cefuzonam‡
Cephamycin (Cefoxitin
Cefotetan
Cefminox‡
Cefbuperazone‡
Cefmetazole‡)
Carbacephem (Loracarbef‡)
3rd generation
Cefixime#
Ceftriaxone#
Cefotaxime#
Antipseudomonal (Ceftazidime#
Cefoperazone‡)
Cefdinir
Cefcapene
Cefdaloxime
Ceftizoxime
Cefmenoxime
Cefpiramide
Cefpodoxime
Ceftibuten
Cefditoren
Cefotiam‡
Cefetamet‡
Cefodizime‡
Cefpimizole‡
Cefsulodin‡
Cefteram‡
Ceftiolene‡
Oxacephem (Flomoxef‡
Latamoxef‡)
4th generation
Cefepime
Cefozopran‡
Cefpirome
Cefquinome‡
5th generation
Ceftaroline fosamil
Ceftolozane
Ceftobiprole
Siderophore
Cefiderocol#
Veterinary
Ceftiofur
Cefquinome
Cefovecin
Monobactams
Aztreonam
Tigemonam‡
Carumonam‡
Nocardicin A‡
β-lactamase inhibitors
Penam (Sulbactam
Tazobactam)
Clavam (Clavulanic acid)
non-β-lactam (Relebactam
Avibactam
Vaborbactam)
Combinations
Amoxicillin/clavulanic acid#
Ampicillin/flucloxacillin
Ampicillin/sulbactam (Sultamicillin)
Benzathine benzylpenicillin/procaine benzylpenicillin
Cefoperazone/sulbactam
Ceftazidime/avibactam
Ceftolozane/tazobactam
Imipenem/cilastatin#
Imipenem/cilastatin/relebactam
Meropenem/vaborbactam
Panipenem/betamipron
Piperacillin/tazobactam
Ticarcillin/clavulanic acid
PolypeptidesGlycopeptides
Inhibit PG chain elongation: Vancomycin# (Oritavancin
Telavancin)
Teicoplanin (Dalbavancin)
Ramoplanin§
Ristocetin‡
Avoparcin
Lipopeptides
Insert into bacterial cell wall causing perforation and depolarization: Daptomycin
Surfactin
Polymyxins
Bind to LPS in the outer bacterial membrane, acting in detergent-like fashion: Colistin
Polymyxin B
Intracellular
Inhibit PG subunit synthesis and transport: NAM synthesis inhibition (Fosfomycin)
DADAL/AR inhibitors (Cycloserine)
bactoprenol inhibitors (Bacitracin)
Other
Hydrolyze NAM-NAG
lysozyme
Tyrothricin
Gramicidin
Tyrocidine
Isoniazid#
Teixobactin

#WHO-EM
‡Withdrawn from market
Clinical trials:
†Phase III
§Never to phase III

vteGlaxoSmithKlineSubsidiaries
GlaxoSmithKline Pakistan
GlaxoSmithKline Pharmaceuticals Ltd
Stiefel Laboratories
Tesaro
ViiV Healthcare (85%)
Predecessors,acquisitions
Allen & Hanburys
Beecham Group
Block Drug
Burroughs Wellcome
Glaxo
Glaxo Wellcome
Human Genome Sciences
Recherche et Industrie Thérapeutiques
Reliant Pharmaceuticals
S. E. Massengill Company
SmithKline Beecham
Smith, Kline & French
ProductsCurrentPharma
Advair
Alli
Augmentin
Avandia
Beconase
Boniva
Flixonase
Hycamtin
Lamictal
Paxil/Seroxat
Serlipet
Tagamet
Ventolin
Wellbutrin/Zyban
Zantac … more
Vaccines
Hepatyrix
Pandemrix
Shingrix
Twinrix
Other
Aquafresh
Centrum
Horlicks
Nicoderm
Nicorette
NiQuitin
Sensodyne
Tums … more
Former
BC Powder
Geritol
Goody's Powder
Lucozade
Ribena
PeopleBoard of Directors
Philip Hampton
Emma Walmsley
Simon Dingemans
Roy M. Anderson
Manvinder Banga 
Patrick Vallance
Vivienne Cox
Lynn Elsenhans
Jesse Goodman
Judy Lewent
Urs Rohner
Laurie Glimcher
Other
Thomas Beecham
Silas M. Burroughs
Mahlon Kline
John K. Smith
Henry Wellcome
Andrew Witty
Chris Gent
Litigation
Canada v. GlaxoSmithKline Inc.
Christopher v. SmithKline Beecham Corp.
GlaxoSmithKline Services Unlimited v Commission
United States v. Glaxo Group Ltd.
United States v. GlaxoSmithKline
Other
Drug Industry Documents Archive
GlaxoSmithKline Prize
Side Effects
Study 329

 Category

vtePhenethylaminesPhenethylamines
Psychedelics: 25B-NBOMe
25C-NBOMe
25D-NBOMe
25I-NBOMe
25N-NBOMe
2C-B
2C-B-AN
2C-Bn
2C-Bu
2C-C
2C-CN
2C-CP
2C-D
2C-E
2C-EF
2C-F
2C-G
2C-G-1
2C-G-2
2C-G-3
2C-G-4
2C-G-5
2C-G-6
2C-G-N
2C-H
2C-I
2C-iP
2C-N
2C-NH2
2C-O
2C-O-4
2C-P
2C-Ph
2C-SE
2C-T
2C-T-2
2C-T-3
2C-T-4
2C-T-5
2C-T-6
2C-T-7
2C-T-8
2C-T-9
2C-T-10
2C-T-11
2C-T-12
2C-T-13
2C-T-14
2C-T-15
2C-T-16
2C-T-17
2C-T-18
2C-T-19
2C-T-20
2C-T-21
2C-T-22
2C-T-22.5
2C-T-23
2C-T-24
2C-T-25
2C-T-27
2C-T-28
2C-T-30
2C-T-31
2C-T-32
2C-T-33
2C-TFE
2C-TFM
2C-YN
2C-V
Allylescaline
DESOXY
Escaline
Isoproscaline
Jimscaline
Macromerine
MEPEA
Mescaline
Metaescaline
Methallylescaline
Proscaline
Psi-2C-T-4
TCB-2
Stimulants: Phenylethanolamine

Hordenine
Phenethylamine
Phenpromethamine
α-Methylphenethylamine (amphetamine)
β-Methylphenethylamine
m-Methylphenethylamine
N-Methylphenethylamine
o-Methylphenethylamine
p-Methylphenethylamine
Methylphenidate
Entactogens: Lophophine
MDPEA
MDMPEAOthers: BOH
DMPEA
Amphetamines
Psychedelics: 3C-AL
3C-BZ
3C-E
3C-MAL
3C-P
Aleph
Beatrice
Bromo-DragonFLY
D-Deprenyl
DMA
DMCPA
DMMDA
DOB
DOC
DOEF
DOET
DOI
DOM
DON
DOPR
DOTFM
Ganesha
MMDA
MMDA-2
Psi-DOM
TMA
TeMA
ZDCM-04Stimulants: 2-FA
2-FMA
3-FA
3-FMA
Acridorex
Alfetamine
Amfecloral
Amfepentorex
Amphetamine (Dextroamphetamine, Levoamphetamine)
Amphetaminil
Benfluorex
Benzphetamine
Cathine
Clobenzorex
Dimethylamphetamine
Ephedrine
Etilamfetamine
Fencamfamin
Fencamine
Fenethylline
Fenfluramine (Dexfenfluramine, Levofenfluramine)
Fenproporex
Flucetorex
Fludorex
Formetorex
Furfenorex
Gepefrine
4-Hydroxyamphetamine
Iofetamine
Isopropylamphetamine
Lefetamine
Lisdexamfetamine
Mefenorex
Metaraminol
Methamphetamine (Dextromethamphetamine, Levomethamphetamine)
Methoxyphenamine
MMA
Morforex
Norfenfluramine
L-Norpseudoephedrine
N,alpha-Diethylphenylethylamine
Oxifentorex
Oxilofrine
Ortetamine
PBA
PCA
PFA
PFMA
PIA
PMA
PMEA
PMMA
Phenylpropanolamine
Pholedrine
Prenylamine
Propylamphetamine
Pseudoephedrine
Sibutramine
Tiflorex
Tranylcypromine
Xylopropamine
ZylofuramineEntactogens: 4-FA
4-FMA
4-MA
4-MMA
4-MTA
5-APB
5-APDB
5-EAPB
5-IT
5-MAPB
5-MAPDB
6-APB
6-APDB
6-Chloro-MDMA
6-EAPB
6-IT
6-MAPB
6-MAPDB
EDA
IAP
2,3-MDA
3,4-MDA (tenamfetamine)
MDEA
MDHMA
MDMA (midomafetamine)
MDOH
Methamnetamine
MMDMA
Naphthylaminopropane
TAPOthers: 3,4-DCA
Amiflamine
DiFMDA
Selegiline (also D-Deprenyl)
Phentermines
Stimulants: Chlorphentermine
Cloforex
Clortermine
Etolorex
Mephentermine
Pentorex
PhentermineEntactogens: MDPH
MDMPHOthers: Cericlamine
Cathinones
Stimulants: 3-FMC
4-MC
4-BMC
4-CMC
4-EMC
4-FMC
4-MEC
4-MeMABP
4-MPD
Amfepramone
Benzedrone
Brephedrone
Buphedrone
Bupropion
Cathinone
Dimethylcathinone
Ethcathinone
Eutylone
Hydroxybupropion
Methcathinone
Methedrone
NEB
N-Ethylhexedrone
N-Ethylpentedrone
Pentedrone
Pentylone
RadafaxineEntactogens: 3,4-DMMC
3-MMC
Butylone
Ethylone
Methylone
Methylenedioxycathinone
Mephedrone
Phenylisobutylamines
Entactogens: 4-CAB
4-MAB
Ariadne
BDB
Butylone
EBDB
Eutylone
MBDBStimulants: Phenylisobutylamine
Phenylalkylpyrrolidines
Stimulants: α-PBP
α-PHP
α-PPP
α-PVP
MDPBP
MDPPP
MDPV
4-MePBP
4-MePHP
4-MePPP
MOPPP
MOPVP
MPBP
MPHP
MPPP
Naphyrone
PEP
Prolintane
Pyrovalerone
Catecholamines(and close relatives)
6-FNE
6-OHDA
a-Me-DA
a-Me-TRA
Adrenochrome
Ciladopa
D-DOPA (Dextrodopa)
Dimetofrine
Dopamine
Epinephrine
Epinine
Etilefrine
Ethylnorepinephrine
Fenclonine
Ibopamine
Isoprenaline
Isoetarine
L-DOPA (Levodopa)
L-DOPS (Droxidopa)
L-Phenylalanine
L-Tyrosine
m-Tyramine
Metanephrine
Metaraminol
Metaterol
Metirosine
Methyldopa
N,N-Dimethyldopamine
Nordefrin (Levonordefrin)
Norepinephrine
Norfenefrine (m-Octopamine)
Normetanephrine
Orciprenaline
p-Octopamine
p-Tyramine
Phenylephrine
Synephrine
Miscellaneous
AL-LAD
Amidephrine
Arbutamine
Cafedrine
Denopamine
Desvenlafaxine
Diphenidine
Dizocilpine
Dobutamine
Dopexamine
Ephenidine
Etafedrine
ETH-LAD
Famprofazone
Fluorolintane
Hexapradol
IP-LAD
Lysergic acid amide
Lysergic acid 2-butyl amide
Lysergic acid 2,4-dimethylazetidide
Lysergic acid diethylamide
Methoxamine
Methoxphenidine
MT-45
PARGY-LAD
Phenibut
PRO-LAD
Pronethalol
Salbutamol (Levosalbutamol)
Solriamfetol
Theodrenaline
Thiamphenicol
UWA-101
Venlafaxine

.mw-parser-output .portal-bar{font-size:88%;font-weight:bold;display:flex;justify-content:center;align-items:baseline}.mw-parser-output .portal-bar-bordered{padding:0 2em;background-color:#fdfdfd;border:1px solid #a2a9b1;clear:both;margin:1em auto 0}.mw-parser-output .portal-bar-unbordered{padding:0 1.7em;margin-left:0}.mw-parser-output .portal-bar-header{margin:0 1em 0 0.5em;padding:0.2em 0;flex:0 0 auto;min-height:24px;line-height:22px}.mw-parser-output .portal-bar-content{display:flex;flex-flow:row wrap;align-items:baseline;flex:0 1 auto;padding:0.15em 0;column-gap:1em}.mw-parser-output .portal-bar-item{display:flex;align-items:baseline;margin:0.15em 0;min-height:24px;text-align:left}.mw-parser-output .portal-bar-logo{width:22px;line-height:22px;margin:0 0.2em;text-align:right}.mw-parser-output .portal-bar-link{margin:0 0.2em;text-align:left}@media screen and (max-width:768px){.mw-parser-output .portal-bar{font-size:88%;font-weight:bold;display:flex;flex-flow:column wrap}.mw-parser-output .portal-bar-header{text-align:center;flex:0;padding-left:0.5em;margin:0 auto}.mw-parser-output .portal-bar-content{display:flex;flex-flow:row wrap;align-items:baseline;flex:0;margin:0 auto;column-gap:1em;border-top:1px solid #a2a9b1}}.mw-parser-output .navbox+link+.portal-bar-bordered{margin-top:-1px}.mw-parser-output .navbox+style+.portal-bar-bordered{margin-top:-1px}.mw-parser-output .portal-bar+.navbox-styles+.navbox{margin-top:-1px}Portal:Medicine





